Di Bei
Johnson & Johnson (United States)(US)
Publications by Year
Research Areas
Phytochemicals and Antioxidant Activities, Advanced biosensing and bioanalysis techniques, Systemic Lupus Erythematosus Research, HER2/EGFR in Cancer Research, Cytokine Signaling Pathways and Interactions
Most-Cited Works
- → Engineering Nanomedicines for Improved Melanoma Therapy: Progress and Promises(2010)97 cited
- → Formulation of Dacarbazine-Loaded Cubosomes—Part I: Influence of Formulation Variables(2009)83 cited
- → Formulation of Dacarbazine-loaded Cubosomes. Part III. Physicochemical Characterization(2010)59 cited
- → First‐in‐human study of deucravacitinib: A selective, potent, allosteric small‐molecule inhibitor of tyrosine kinase 2(2022)53 cited
- → Pharmacokinetics of protocatechuic acid in mouse and its quantification in human plasma using LC–tandem mass spectrometry(2012)45 cited
- → Enzyme-Transporter-Mediated Drug Interactions with Small Molecule Tyrosine Kinase Inhibitors(2014)43 cited
- → Formulation of Dacarbazine-loaded Cubosomes—Part II: Influence of Process Parameters(2009)41 cited
- → Localisation of Microtubule‐Associated Protein 1B Phosphorylation Sites Recognised by Monoclonal Antibody SMI‐31(1997)38 cited
- → Activity-regulated, cytoskeleton-associated protein (Arc) is essential for visceral endoderm organization during early embryogenesis(2000)25 cited
- → Pharmacokinetics and tissue distribution of 5,7-dimethoxyflavone in mice following single dose oral administration(2015)25 cited